¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent Updates in GU Cancers : 2022-04-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent Updates in GU Cancers : 2022-04-22
±³À°ÀÏÀÚ : 2022-04-22
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F)  
±³À°ÁÖÁ¦ : Recent Updates in GU Cancers
ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ
¿¬¶ôó : 02-735-2857  
À̸ÞÀÏ : meetings@ksmo.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 90,000¿ø      
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ 50000¿ø ÀüÀÓÀÇ 30000 ¿ø ±âŸ 70000¿ø ´çÀϵî·Ï : Àü¹®ÀÇ 70000¿ø ÀüÀÓÀÇ 50000 ¿ø ±âŸ 90000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 09:30~09:55 First-line systemic therapy for metastatic renal cell carcinoma  ±è¹Ì¼Ò(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 09:55~10:20 Sequencing therapies after failure of first-line treatment in mRCC  ±è¼¼Çö(ºÐ´ç¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 10:20~10:45 Localized disease, Surgery and perioperative therapy  ±èÈñÁØ(Á߾Ӵ뺴¿ø) 
Åä·Ð 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 10:45~10:55 Discussion  () 
È޽Ġ04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 10:55~11:05 Coffee Break  () 
±³À°½Ã°£ 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 11:05~11:30 Metastatic disease, first-line systemic therapy  ±èÀÎÈ£(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 11:30~11:55 Metastatic disease, 2nd or later (including new agents)  ÀÓÁÖÇÑ(ÀÎÇϴ뺴¿ø) 
±³À°½Ã°£ 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 11:55~12:20 Localized disease - NMIBC, MIBC, and UTUC  ¹ü½ÂÈÆ(¿¬¼¼¾Ïº´¿ø) 
Åä·Ð 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 12:20~12:30 Discussion  () 
±³À°½Ã°£ 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 12:30~13:10 Transforming treatment of advanced UC using first-line maintenance therapy : BAVENCIO(Avelumab)  ¹ÚÀαÙ(¼­¿ï¾Æ»êº´¿ø) 
È޽Ġ04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 13:10~13:30 Coffee Break  () 
±³À°½Ã°£ 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 13:30~13:55 mHSPCa, systemic therapy  ¹Ú±Ç¿À(¾ç»êºÎ»ê´ëº´¿ø) 
±³À°½Ã°£ 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 13:55~14:20 mCRPCa, systemic therapy including new agents  ¼Õº´¼®(ÀÎÁ¦´ë»ó°è¹éº´¿ø) 
±³À°½Ã°£ 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 14:20~14:45 Localized disease, diagnosis, systemic therapy and radiotherapy  Çã¼®Àç(µ¿¾Æ´ëº´¿ø) 
Åä·Ð 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 14:45~14:55 Discussion  () 
È޽Ġ04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 14:55~15:05 Coffee Break  () 
±³À°½Ã°£ 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 15:05~15:30 Germ cell tumor  ±èÁø¿µ(°è¸í´ëµ¿»êº´¿ø) 
±³À°½Ã°£ 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 15:30~15:55 Rare GU Cancer (ACC, pheo, penile, urethra)  À±½Å±³(¼­¿ï¾Æ»êº´¿ø) 
Åä·Ð 04-22 ¼­¿ïµå·¡°ï½ÃƼ ½Å¶ó(3F) 15:55~16:05 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent Updates in GU Cancers : 2022-04-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) ¾È°ú ±Ý¿äÁý´ãȸ : 2022-04-22
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ °­¿øÁöȸ Áý´ãȸ : 2022-04-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20589 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GI Cancer 2024 : 2024-06-14 0 61 2024-04-29
20588 ¼­¿ï ´ëÇÑ°ñ´ë»çÇÐȸ SSBH 2024 (The 12th Seoul Symposium on Bone Health)&Á¦36Â÷ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-06-14 0 60 2024-04-29
20587 ¼­¿ï ´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 2ÀÏÂ÷ : 2024-06-14 0 39 2024-04-29
20586 °æºÏ 2024 ´ëÇÑÆó¾ÏÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-14 0 50 2024-04-29
20585 ¼­¿ï ´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 1ÀÏÂ÷ : 2024-06-13 0 65 2024-04-29
20584 ¼­¿ï ´ëÇÑ°ñ´ë»çÇÐȸ SSBH 2024 (The 12th Seoul Symposium on Bone Health)&Á¦36Â÷ Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-06-13 0 59 2024-04-29
20583 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-ÃÖ½ÅÇü º¸Ã»±â¿Í ¸ÂÃãÇü º¸Ã»±â ó¹æ¿ä·É : 2024-06-13 0 49 2024-04-29
20582 ¼­¿ï °­³²¼¼ºê¶õ½º ¾È°ú Áö¿ªÀÇ»çÁý´ãȸ(³­Ä¡¼º °¢¸· Áúȯ) : 2024-06-11 0 69 2024-04-29
20581 ¼­¿ï [¿Â¶óÀÎ] Á¦274ȸ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿ù·Ê ÇмúÁý´ãȸ(Æó±â´É°ú ±â°üÁö°ú¹Î¼º) : 2024-06-11 0 46 2024-04-29
20580 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø [¿Â¶óÀÎ] Á¦ 26 ȸ ¿Ü·¡Â÷¿øÀÇ ¼Ò¾Æû¼Ò³â°ú ÀÓ»ó : 2024-06-09 0 48 2024-04-29
20579 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø ¼øȯ±â³»°ú 16ȸ KOALA Symposium 2024 : 2024-06-09 0 44 2024-04-29
20578 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ (¿Â¶óÀÎ) Á¦3ȸ ¼ö¸é°øµ¿½ÉÆ÷Áö¾ö : 2024-06-09 0 59 2024-04-29
20577 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ 2024 ´ç´¢º´ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-09 0 70 2024-04-29
20576 ¼­¿ï 2024 ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08 0 63 2024-04-29
20575 ¼­¿ï 2024 »ó¹Ý±â ´ëÇÑÇ÷¾×ÇÐȸ ´Ù¹ß°ñ¼öÁ¾¿¬±¸È¸ ½ÉÆ÷Áö¾ö(2024 »ó¹Ý±â KMMWP workshop & Àӻ󿬱¸¸ðÀÓ) : 2024-06-08 0 49 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷